Header Logo

Connection

CHRIS AMOS to Prognosis

Back to Details
This is a "connection" page, showing publications CHRIS AMOS has written about Prognosis.
CHRIS AMOS
Connection Strength
1.635
Prognosis
  1. Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer. J Thorac Oncol. 2023 09; 18(9):1184-1198.
    View in: PubMed
    Score: 0.104
  2. An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors. Int J Cancer. 2020 11 01; 147(9):2621-2633.
    View in: PubMed
    Score: 0.085
  3. Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival. Mol Carcinog. 2020 06; 59(6):640-650.
    View in: PubMed
    Score: 0.084
  4. The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):126-135.
    View in: PubMed
    Score: 0.066
  5. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):251-60.
    View in: PubMed
    Score: 0.051
  6. Genomic sequencing in cancer. Cancer Lett. 2013 Nov 01; 340(2):161-70.
    View in: PubMed
    Score: 0.050
  7. Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1213-21.
    View in: PubMed
    Score: 0.049
  8. Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer. J Thorac Oncol. 2009 Oct; 4(10):1195-201.
    View in: PubMed
    Score: 0.041
  9. Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact. J Thorac Oncol. 2026 Jan; 21(1):41-76.
    View in: PubMed
    Score: 0.031
  10. Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma. Clin Cancer Res. 2025 Dec 15; 31(24):5225-5236.
    View in: PubMed
    Score: 0.031
  11. Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium. Carcinogenesis. 2025 Apr 03; 46(2).
    View in: PubMed
    Score: 0.030
  12. DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance. JCO Precis Oncol. 2024 Nov; 8:e2400375.
    View in: PubMed
    Score: 0.029
  13. Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions. Prog Cardiovasc Dis. 2024 Sep-Oct; 86:79-85.
    View in: PubMed
    Score: 0.029
  14. The prognostic effect of infiltrating immune cells is shaped by proximal M2 macrophages in lung adenocarcinoma. Mol Cancer. 2024 Sep 04; 23(1):185.
    View in: PubMed
    Score: 0.029
  15. Prognostic stratification in DLBCL patients with aberrant MYC gene. Br J Haematol. 2024 Nov; 205(5):1782-1793.
    View in: PubMed
    Score: 0.028
  16. What is the additive value of nutritional deficiency to VA-FI in the risk assessment for heart failure patients? J Nutr Health Aging. 2024 Jul; 28(7):100253.
    View in: PubMed
    Score: 0.028
  17. Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy. Transplant Cell Ther. 2023 11; 29(11):685.e1-685.e7.
    View in: PubMed
    Score: 0.027
  18. A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma. Br J Cancer. 2022 11; 127(9):1691-1700.
    View in: PubMed
    Score: 0.025
  19. A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma. Genome Med. 2022 01 12; 14(1):5.
    View in: PubMed
    Score: 0.024
  20. Pan-cancer evaluation of gene expression and somatic alteration data for cancer prognosis prediction. BMC Cancer. 2021 Sep 25; 21(1):1053.
    View in: PubMed
    Score: 0.023
  21. Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung Cancer. Cancer Res. 2021 06 15; 81(12):3162-3173.
    View in: PubMed
    Score: 0.023
  22. Tumor immune infiltration estimated from gene expression profiles predicts colorectal cancer relapse. Oncoimmunology. 2021 03 09; 10(1):1862529.
    View in: PubMed
    Score: 0.022
  23. Prognostic Role of Programmed Cell Death 1 Ligand 1 in Resectable Pleural Mesothelioma. Ann Thorac Surg. 2021 11; 112(5):1575-1583.
    View in: PubMed
    Score: 0.022
  24. A new efficient method to detect genetic interactions for lung cancer GWAS. BMC Med Genomics. 2020 10 30; 13(1):162.
    View in: PubMed
    Score: 0.022
  25. Cancer prognosis prediction using somatic point mutation and copy number variation data: a comparison of gene-level and pathway-based models. BMC Bioinformatics. 2020 Oct 20; 21(1):467.
    View in: PubMed
    Score: 0.022
  26. Genetic Determinants of Lung Cancer Prognosis in Never Smokers: A Pooled Analysis in the International Lung Cancer Consortium. Cancer Epidemiol Biomarkers Prev. 2020 10; 29(10):1983-1992.
    View in: PubMed
    Score: 0.021
  27. Genetic variants in TKT and DERA in the nicotinamide adenine dinucleotide phosphate pathway predict melanoma survival. Eur J Cancer. 2020 09; 136:84-94.
    View in: PubMed
    Score: 0.021
  28. A gene expression-based immune signature for lung adenocarcinoma prognosis. Cancer Immunol Immunother. 2020 Sep; 69(9):1881-1890.
    View in: PubMed
    Score: 0.021
  29. Comparison of pathway and gene-level models for cancer prognosis prediction. BMC Bioinformatics. 2020 Feb 28; 21(1):76.
    View in: PubMed
    Score: 0.021
  30. Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers. Br J Cancer. 2020 02; 122(3):405-412.
    View in: PubMed
    Score: 0.021
  31. Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma. Neoplasia. 2019 11; 21(11):1102-1109.
    View in: PubMed
    Score: 0.020
  32. Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer. Cancer Epidemiol Biomarkers Prev. 2019 07; 28(7):1228-1237.
    View in: PubMed
    Score: 0.020
  33. Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression. J Invest Dermatol. 2019 11; 139(11):2352-2358.e3.
    View in: PubMed
    Score: 0.020
  34. Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival. Carcinogenesis. 2019 04 29; 40(2):279-288.
    View in: PubMed
    Score: 0.020
  35. Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival. Int J Cancer. 2019 11 15; 145(10):2619-2628.
    View in: PubMed
    Score: 0.019
  36. Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst. 2019 02 01; 111(2):146-157.
    View in: PubMed
    Score: 0.019
  37. Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis. Cancer Epidemiol Biomarkers Prev. 2019 05; 28(5):935-942.
    View in: PubMed
    Score: 0.019
  38. Sex-specific gene and pathway modeling of inherited glioma risk. Neuro Oncol. 2019 01 01; 21(1):71-82.
    View in: PubMed
    Score: 0.019
  39. Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2019 03; 28(3):555-562.
    View in: PubMed
    Score: 0.019
  40. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis. Mol Cancer Res. 2019 01; 17(1):109-119.
    View in: PubMed
    Score: 0.019
  41. Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival. Mol Carcinog. 2018 Jan; 57(1):22-31.
    View in: PubMed
    Score: 0.018
  42. Somatic mutation analysis in melanoma using targeted next generation sequencing. Exp Mol Pathol. 2017 10; 103(2):172-177.
    View in: PubMed
    Score: 0.017
  43. Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. J Invest Dermatol. 2017 08; 137(8):1749-1756.
    View in: PubMed
    Score: 0.017
  44. Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes. J Invest Dermatol. 2017 08; 137(8):1792-1795.
    View in: PubMed
    Score: 0.017
  45. Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients. PLoS One. 2017; 12(4):e0175850.
    View in: PubMed
    Score: 0.017
  46. Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival. Int J Cancer. 2017 03 15; 140(6):1270-1279.
    View in: PubMed
    Score: 0.017
  47. Genetic variants in the PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific survival. Int J Cancer. 2016 Dec 15; 139(12):2730-2737.
    View in: PubMed
    Score: 0.016
  48. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis. EBioMedicine. 2016 Sep; 11:219-226.
    View in: PubMed
    Score: 0.016
  49. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer. J Thorac Oncol. 2016 Jan; 11(1):52-61.
    View in: PubMed
    Score: 0.016
  50. Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1101-10.
    View in: PubMed
    Score: 0.015
  51. Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes. J Invest Dermatol. 2015 Sep; 135(9):2266-2272.
    View in: PubMed
    Score: 0.015
  52. Prognostic relevance of acquired uniparental disomy in serous ovarian cancer. Mol Cancer. 2015 Feb 03; 14:29.
    View in: PubMed
    Score: 0.015
  53. Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival. Int J Cancer. 2015 Aug 01; 137(3):638-45.
    View in: PubMed
    Score: 0.015
  54. Polymorphisms in MicroRNAs are associated with survival in non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2503-11.
    View in: PubMed
    Score: 0.014
  55. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2014 Jul; 46(7):736-41.
    View in: PubMed
    Score: 0.014
  56. Role of selected genetic variants in lung cancer risk in African Americans. J Thorac Oncol. 2013 Apr; 8(4):391-7.
    View in: PubMed
    Score: 0.013
  57. Polymorphisms of nucleotide excision repair genes predict melanoma survival. J Invest Dermatol. 2013 Jul; 133(7):1813-21.
    View in: PubMed
    Score: 0.013
  58. Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients. Carcinogenesis. 2013 Feb; 34(2):299-306.
    View in: PubMed
    Score: 0.013
  59. Association of smoking with tumor size at diagnosis in non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):378-83.
    View in: PubMed
    Score: 0.011
  60. A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians. Mol Carcinog. 2012 May; 51(5):433-8.
    View in: PubMed
    Score: 0.011
  61. Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysis. Mol Carcinog. 2010 Nov; 49(11):974-80.
    View in: PubMed
    Score: 0.011
  62. Accuracy of the BRCAPRO model among women with bilateral breast cancer. Cancer. 2009 Feb 15; 115(4):725-30.
    View in: PubMed
    Score: 0.010
  63. Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Ann Surg Oncol. 2009 Feb; 16(2):431-9.
    View in: PubMed
    Score: 0.010
  64. Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care center. Cancer Detect Prev. 2008; 32(2):101-8.
    View in: PubMed
    Score: 0.009
  65. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol. 2006 Aug 10; 24(23):3789-98.
    View in: PubMed
    Score: 0.008
  66. An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. J Natl Cancer Inst. 2002 Jul 17; 94(14):1091-9.
    View in: PubMed
    Score: 0.006
  67. Epidemiologic determinants of clinically relevant prostate cancer. Int J Cancer. 2000 May 20; 89(3):259-64.
    View in: PubMed
    Score: 0.005
  68. Late onset and reactivation of chorioretinitis in children with congenital cytomegalovirus infection. Pediatr Infect Dis J. 1994 Dec; 13(12):1139-42.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.